2Anno·

Small first additional purchase, if it falls even lower, even more ...


If Motley Fool wants to go "all in", it would be stupid not to risk another ant as well


Closer

18.01
BioCryst Pharms logo
Acquistato a 13,60 €
4 Commenti

immagine del profilo
First ant position , second NVIDIA has KUV 40 and apparently Biocryst has a unique selling proposition with its drug
Mostra la risposta
immagine del profilo
Since when does Motley Fool go "all in" anywhere?
Visualizza tutti 2 ulteriori risposte
Partecipa alla conversazione